Increasing genetic disorders are driving the Amondys 45 Market 2026

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Amondys 45 Market Expected To Change Between 2026 And 2030?

Historical growth was driven by restricted therapeutic choices for DMD, encouragement provided for rare disease medications, increased accessibility to genetic screening, initial studies in antisense methodologies, and the dedicated work of patient advocacy groups.

The projected growth throughout the forecast period is due to breakthroughs in gene-based therapies, more widespread newborn screening programs, the expansion of exon-specific medications, consistent regulatory fast-tracking, and a rise in clinical trial investments.

Key trends anticipated during the forecast period involve the increased adoption of exon skipping therapies, the widening application of precision genetic medicine, a greater focus on rare neuromuscular disorders, targeted treatments facilitated by early diagnosis, and growing regulatory support for orphan drugs.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19968&type=smp

Which Economic Or Industry Drivers Are Impacting The Amondys 45 Market?

The amondys 45 market is anticipated to expand due to the increasing incidence of genetic disorders. These health conditions stem from DNA irregularities in individuals, often resulting from single or multiple gene mutations, chromosomal alterations, or a mix of genetic and environmental influences. This increase in genetic disease prevalence can be attributed to heightened public awareness and progress in diagnostic tools, facilitating more precise and timely identification of conditions that were previously undiagnosed. Amondys 45 offers a solution for managing genetic disorders by specifically targeting particular dystrophin gene mutations, proving beneficial for Duchenne muscular dystrophy patients who need exon 45 skipping. The therapy promotes better muscle function by allowing the body to produce a functional, albeit shorter, dystrophin protein, thereby aiding in slowing the disease’s progression and improving patient results. For example, the National Blood Authority, an Australian blood management agency, reported in July 2025 that the number of patients with hereditary haemophilia A (HMA) in 2023–2024 was 2,788, an increase from 2,681 patients in 2022–2023. Consequently, the expanding access to genetic testing is fueling the growth of the amondys 45 market.

How Is The Amondys 45 Market Structured Across Different Segments?

The amondys 45 market covered in this report is segmented –

1) By Indication: Duchenne Muscular Dystrophy (DMD) – Exon 45 Mutation, Other Genetic Mutations

2) By End-User: Adult, Geriatric, Pediatric

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Which Major Players Dominate The Amondys 45 Market?

Major companies operating in the amondys 45 market are Sarepta Therapeutics Inc.

Read the full amondys 45 market report here:

https://www.thebusinessresearchcompany.com/report/amondys-45-global-market-report

What Are The Top-Performing Regions Within The Amondys 45 Market?

North America was the largest region in the amondys 45 market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the amondys 45 market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Amondys 45 Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19968&type=smp

Browse Through More Reports Similar to the Global Amondys 45 Market 2026, By The Business Research Company

Luxury Resale Market Report 2026

https://www.thebusinessresearchcompany.com/report/luxury-resale-global-market-report

Automotive Silicone Market Report 2026

https://www.thebusinessresearchcompany.com/report/automotive-silicone-global-market-report

Wholesale And Distribution Automotive Aftermarket Market Report 2026

https://www.thebusinessresearchcompany.com/report/wholesale-and-distribution-automotive-aftermarket-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795